close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Companies Business Social issues
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags US: News Surgical procedures Biotech and Pharmaceuticals
From CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
Tags US: News Pharmaceuticals Weight management
From CNBC.com News
Stocks making the biggest premarket moves: Walgreens, Kellogg, Eli Lilly, Delta and more
Tags Stock markets American Equity Investment Life Holding Co Eli Lilly and Co
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Economy Business News Lordstown Motors Corp
From CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Tags US: News Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Tags Biotech and Pharmaceuticals Breaking news Novo Nordisk A/S
From CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Tags Pfizer Inc Science Health care industry
From CNBC.com News
Nearly 50% of top tech executives across the economy say A.I. is now their biggest spend: CNBC survey
Tags Technology: Trends Leadership Technology Executive Council
From CNBC.com News
Stocks making the biggest moves midday: Overstock, Tesla, Accenture and more
Tags Market Insider Economy Root Inc
From CNBC.com News
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
Tickers LAW LAWS
Tags Biotechnology Health & Science Lawsuits
From CNBC.com News
CNBC Daily Open: Rethinking the rally
Tags Asia Markets Apple Inc Alphabet Inc
From CNBC.com News
Eli Lilly to acquire Dice Therapeutics for $2.4 billion in autoimmune treatment push
Tags Business News Business Companies
From CNBC.com News
Stocks making the biggest premarket moves: Alibaba, Dice Therapeutics, Avis and more
Tags Breaking News: Markets Business stocks
From CNBC.com News
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
Tags Policy US: News Abbvie Inc
From CNBC.com News
Cramer explains how four different camps of buyers see mixed messages in the Fed's rate strategy
Tags Investment Strategy Johnson & Johnson Stock Picks
From CNBC.com News
Eli Lilly CEO says Medicare price negotiations could harm drug development
Tags Biotech and Pharmaceuticals Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Cramer's Lightning Round:
Tags Rivian Automotive Inc Lam Research Corp Everi Holdings Inc
From CNBC.com News
Cramer's Lightning Round:
Tags Southern Co Markets Coinbase Global Inc
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Biogen Inc stocks Business
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Policy US: News Eli Lilly and Co
From CNBC.com News
With debt crisis looming, look to these names and sectors, Jim Cramer says
Tags Eli Lilly and Co Stock markets U/S/ Markets
From CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Tags Companies Business Business News
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags Policy US: News US Top News and Analysis
From CNBC.com News
Stocks making the biggest moves midday: CVS Health, Eli Lilly, Clorox, Yum and more
Tags Wingstop Inc Generac Holdings Inc ImmunoGen Inc
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Finance Economy Market Insider
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags Health care industry Science Alzheimer's disease
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Epidemics Biotechnology Health & Science
From CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
Tags Pharmaceuticals Eli Lilly and Co Biotechnology
From CNBC.com News
Thursday's rally showed the power of stock picking, Jim Cramer says
Tags Markets Mad Money Investing
From CNBC.com News
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today